A randomized phase II trial of adjuvant pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153.

被引：0
|
作者：
Durm, Greg Andrew
Furqan, Muhammad
Hall, Richard Delmar
Chiappori, Alberto
Ma, Patrick C.
Feldman, Lawrence Eric
Kulkarni, Amit
Haigentz, Missak
Ganti, Apar Kishor
Owen, Dwight Hall
Sanborn, Rachel E.
Hanna, Nasser H.
机构：
[1] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, PA USA
[2] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[3] Univ Virginia, Sch Med, Charlottesville, VA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[6] Univ Illinois Hosp & Hlth Sci Syst, Jesse Brown VA Med Ctr, Chicago, IL USA
[7] Univ Minnesota, Minneapolis, MN USA
[8] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[9] Univ Nebraska Med Ctr, VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA
[10] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[11] Earle A Chiles Res Inst, Providence Canc Inst, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8118
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized phase II trial of adjuvant pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153.
    Durm, Greg Andrew
    Furqan, Muhammad
    Feldman, Lawrence Eric
    Patel, Malini
    Hall, Richard Delmar
    Jalal, Shadia Ibrahim
    Birdas, Thomas J.
    Kesler, Kenneth
    Rieger, Karen Marie
    Ceppa, DuyKhanh
    Hanna, Nasser H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm
    Durm, G.
    Birdas, T.
    Liu, H.
    Jalal, S.
    Kesler, K.
    Rieger, K.
    Ceppa, D.
    Hanna, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S257 - S258
  • [3] Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study
    Malhotra, Jyoti
    Chiappori, Alberto
    Fujioka, Naomi
    Hanna, Nasser H.
    Feldman, Lawrence E.
    Patel, Malini
    Moore, Dirk
    Chen, Chunxia
    Jabbour, Salma K.
    [J]. LUNG CANCER, 2024, 195
  • [4] A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)LUN 17-139
    Ardeshir-Larijani, Fatemeh
    Althouse, Sandra K.
    Leal, Ticiana
    Feldman, Lawrence Eric
    Abu Hejleh, Taher
    Patel, Malini
    Gentzler, Ryan D.
    Miller, Adam Ryan
    Hanna, Nasser H.
    [J]. CLINICAL LUNG CANCER, 2022, 23 (07) : 578 - 584
  • [5] A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029
    Salous, Tareq
    Shukla, Nikhil A. A.
    Althouse, Sandra K. K.
    Perkins, Susan M. M.
    Furqan, Muhammad
    Leal, Ticiana
    Traynor, Anne M. M.
    Feldman, Lawrence E. E.
    Hanna, Nasser H. H.
    Durm, Greg A. A.
    [J]. CANCER, 2023, 129 (02) : 264 - 271
  • [6] A phase I trial of plinabulin in combination with nivolumab and ipilimumab in patients with relapsed small cell lung cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17-127) study.
    Malhotra, Jyoti
    Hanna, Nasser H.
    Chiappori, Alberto
    Feldman, Lawrence Eric
    Fujioka, Naomi
    Rybkin, Igor I.
    Jalal, Shadia Ibrahim
    Patel, Malini
    Moore, Dirk
    Chen, Chunxia
    Jabbour, Salma K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] A phase II trial of chemotherapy plus pembrolizumab in patients with advanced NSCLC previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
    Shukla, Nikhil
    Althouse, Sandra K.
    Perkins, Susan
    Furqan, Muhammad
    Leal, Ticiana
    Hanna, Nasser H.
    Durm, Greg Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Adjuvant Chemotherapy for Elderly Patients With Stage I Non-Small Cell Lung Cancer (NSCLC) With Tumors ≥ 4 cm: A SEER-Medicare Analysis
    Malhotra, J.
    Mhango, G.
    Gomez, J. E.
    Smith, C. B.
    Galsky, M. D.
    Strauss, G. M.
    Wisnivesky, J. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S56 - S56
  • [9] Adjuvant chemotherapy for elderly patients with stage I non-small cell lung cancer (NSCLC) with tumors ≥4 cm: A SEER-Medicare analysis.
    Malhotra, Jyoti
    Mhango, Grace
    Gomez, Jorge E.
    Smith, Cardinale B.
    Galsky, Matt D.
    Strauss, Gary M.
    Wisnivesky, Juan P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175
    Gentzler, Ryan D.
    Mohindra, Nisha A.
    Jalal, Shadia, I
    Reckamp, Karen L.
    Hall, Richard D.
    Hanna, Nasser H.
    Chae, Young Kwang
    Koczywas, Marianna
    Helenowski, Irene B.
    Patel, Jyoti D.
    [J]. ONCOLOGIST, 2024, 29 (01): : 47 - 56
12345